ORIGIN AND EVOLUTION OF HIV-1 DRUG RESISTANCE
HIV-1 耐药性的起源和演变
基本信息
- 批准号:8357636
- 负责人:
- 金额:$ 37.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimalsAnti-Retroviral AgentsBloodBlood specimenDrug resistanceEvolutionFamily suidaeFundingGrantHIV-1IndividualInfectionMacacaMeasuresModelingMutationNational Center for Research ResourcesPharmaceutical PreparationsPrimatesPrincipal InvestigatorResearchResearch InfrastructureResistanceResourcesSiteSourceTailTissuesUnited States National Institutes of HealthViralViremiaVirusantiretroviral therapycostdrug resistant virusefavirenzin vivonon-nucleoside reverse transcriptase inhibitorsnucleoside analogtransmission process
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Drug resistance is a significant issue affecting the treatment options of individuals infected with HIV-1. Some drug resistance-conferring mutations can persist for long periods in the host and can be transmitted horizontally and/or vertically to new individuals. How drug resistance-conferring mutations arise during treatment, particularly in anatomical sites other than the blood, is not understood and may affect transmission of drug resistant HIV-1 and persistence of viral reservoirs throughout the body. To date, no studies have longitudinally sampled blood and different anatomical compartments to identify the origins and emergence of drug resistant isolates and to measure antiretroviral drug concentrations at those same sites. In this subcontract, we propose to use a RT-SHIVmne infection model in pig-tailed macaques to study the origin and evolution of HIV-1 drug resistance. The Specific Aims of this project are: (1): To examine longitudinally the emergence of drug resistance-conferring mutations in RT that arise in RT-SHIVmne-infected macaques receiving monotherapy with the nucleoside analog FTC , or the non-nucleoside RT inhibitor efavirenz, in blood and different anatomical compartments; (2): To determine the tissue origin of the re-emergence of wild-type virus and/or persistence of drug resistant virus after discontinuation of monotherapy and after suppression of viremia with combination antiretroviral therapy in the RT-SHIVmne-infected animals; (3): To measure the concentration of antiretroviral drugs in the blood and tissue compartments of RT-SHIVmne-infected macaques described above and correlate these with emergence of resistance. In vivo studies in Specific Aim 1 were initiated in January of 2011.
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。子项目的主要支持
而子项目的主要调查员可能是由其他来源提供的,
包括其它NIH来源。 列出的子项目总成本可能
代表子项目使用的中心基础设施的估计数量,
而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。
耐药性是影响HIV-1感染者治疗选择的一个重要问题。一些耐药性突变可以在宿主体内持续很长时间,并可以水平和/或垂直传播给新的个体。在治疗过程中如何产生耐药性突变,特别是在血液以外的解剖部位,目前尚不清楚,可能会影响耐药性HIV-1的传播和整个身体的病毒储存库的持久性。到目前为止,还没有研究纵向采样血液和不同的解剖隔室,以确定耐药菌株的起源和出现,并在这些相同的网站测量抗逆转录病毒药物浓度。在本研究中,我们建议使用RT-SHIVmne感染模型在猪尾猕猴中研究HIV-1耐药性的起源和演变。本项目的具体目的是:(1):纵向检查RT中产生耐药性的突变的出现,这些突变出现在接受核苷类似物FTC或非核苷RT抑制剂依法韦仑单药治疗的RT-SHIVmne感染猕猴的血液和不同解剖室中;(2):在RT-SHIVmne中,确定在停止单药治疗后和联合抗逆转录病毒治疗抑制病毒血症后野生型病毒重新出现和/或耐药病毒持续存在的组织来源。受感染的动物;(三):测量上述RT-SHIVmne感染猕猴血液和组织隔室中抗逆转录病毒药物的浓度,并将其与耐药性的出现相关联。Specific Aim 1的体内研究于2011年1月启动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shiu-Lok Hu其他文献
Shiu-Lok Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shiu-Lok Hu', 18)}}的其他基金
VIRUS-LIKE PARTICLES WITH STABILIZED TRIMERIC ENVELOPE FOR PRIME BOOST IMMUNIZATION
具有稳定三聚体包膜的病毒样颗粒,用于初免加强免疫
- 批准号:
9530535 - 财政年份:2017
- 资助金额:
$ 37.79万 - 项目类别:
PROTECTIVE EFFICACY OF GLYCAN-MODIFIED ENV VACCINE
聚糖修饰的 ENV 疫苗的保护作用
- 批准号:
8357597 - 财政年份:2011
- 资助金额:
$ 37.79万 - 项目类别:
IMMUNOPATHOGENESIS OF CLADE C SHIV-1157IPD3N4 IN M NEMESTRINA
M Nemestrina 中 C 进化枝 SHIV-1157IPD3N4 的免疫发病机制
- 批准号:
8357596 - 财政年份:2011
- 资助金额:
$ 37.79万 - 项目类别:
INFECTIVITY OF HSIV-VIF CHIMERA IN PIGTAILED MACAQUES
HSIV-VIF 嵌合体在斑尾猕猴中的感染性
- 批准号:
8357599 - 财政年份:2011
- 资助金额:
$ 37.79万 - 项目类别:
COMBINED APPROACH TO BROADLY PROTECTIVE AIDS VACCINES: PROJECT 4
广泛保护性艾滋病疫苗的综合方法:项目 4
- 批准号:
8357598 - 财政年份:2011
- 资助金额:
$ 37.79万 - 项目类别:
INFECTIVITY OF HSIV-VIF CHIMERA IN NEWBORN PIGTAILED MACAQUES
HSIV-VIF 嵌合体在新生短尾猴中的感染性
- 批准号:
8357619 - 财政年份:2011
- 资助金额:
$ 37.79万 - 项目类别:
INTRARECTAL TITRATION OF SHIV 162P4 STOCK
SHIV 162P4 库存的直肠内滴定
- 批准号:
8357586 - 财政年份:2011
- 资助金额:
$ 37.79万 - 项目类别:
INTRARECTAL TITRATION OF SHIV 162P4 STOCK
SHIV 162P4 库存的直肠内滴定
- 批准号:
8172740 - 财政年份:2010
- 资助金额:
$ 37.79万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 37.79万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 37.79万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 37.79万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 37.79万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 37.79万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 37.79万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 37.79万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 37.79万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 37.79万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 37.79万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)














{{item.name}}会员




